PRKN and Parkinson disease: This raises a provocative possibility: as PD progresses, increasing miR-146a-5p might reflect an ongoing inflammatory response, which initially aims to counteract inflammation but might have deleterious side effects such as impairing mitophagy via Parkin downregulation.